tiprankstipranks
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market
KYTX
Kyverna Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see KYTX full AI Analyst Report?

Kyverna Therapeutics, Inc. (KYTX) Income Statement

1,033 Followers

Kyverna Therapeutics, Inc. Income Statement

Last quarter (Q1 2026), Kyverna Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Kyverna Therapeutics, Inc.'s net income was $-39.73M. See Kyverna Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 7.03M$ 5.66M
Gross Profit
$ 0.00$ -2.13M$ -1.71M$ 7.03M$ 5.66M
Operating Expenses
$ 169.83M$ 140.47M$ 60.70M$ 36.41M$ 32.00M
Depreciation and Amortization
$ 1.80M$ 2.13M$ 1.71M$ 1.05M$ 586.00K
EBITDA
$ -159.02M$ -125.20M$ -58.47M$ -27.78M$ -25.76M
Operating Income
$ -169.83M$ -142.60M$ -62.41M$ -29.38M$ -26.35M
Other Income/Expenses
$ 8.52M$ 15.13M$ 2.04M$ 491.00K$ -4.00K
Pretax Income
$ -161.31M$ -127.48M$ -60.37M$ -28.89M$ -26.35M
Net Income
$ -161.31M$ -127.48M$ -60.37M$ -28.89M$ -26.35M
Per Share Metrics
Basic EPS
$ -3.64$ -3.33$ 0.00$ -1.12$ -1.02
Diluted EPS
$ -3.64$ -3.33$ 0.00$ -1.12$ -1.02
Weighted Average Shares Outstanding
 44.26M 38.33M 673.62M 25.80M 25.80M
Weighted Average Shares Outstanding (Diluted)
 44.26M 38.33M 673.62M 25.80M 25.80M
Currency in USD

Kyverna Therapeutics, Inc. Earnings and Revenue History